Location Cincinnati, Ohio, United States Regions Great Lakes, Midwestern US Gender Male
LinkedIn View on LinkedIn
Joseph Gardner is the president and CEO of Aerpio Therapeutics, a biotechnology company that develops new small molecules and monoclonal antibodies for the treatment of vascular disease. He previously held the same position at Akebia Therapeutics.
Gardner holds a bachelor’s degree in biological chemistry from Tulane University and a PhD in
medicinal chemistry from the University of Wisconsin.
